Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Annals of Surgical Oncology|October 31, 2018
Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal AdenocarcinomaWei Jin, Hua-Xiang Xu, Shi-Rong Zhang, et al.World Journal of Gastroenterology|March 10, 2020
Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancerShuai-Shuai Xu, Shuo Li, Hua-Xiang Xu, et al.Angiogenesis|September 1, 2018
Angiogenesis in pancreatic cancer: current research status and clinical implicationsShuo Li, Hua-Xiang Xu, Chun-Tao Wu, et al.Cancer Letters|September 27, 2023
Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinomaTian-Jiao Li, Kai-Zhou Jin, Hong-Yu Zhou, et al.The FEBS Journal|May 28, 2023
Inhibition of epithelial-to-mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinomaKai-Zhou Jin, Ying Wu, Xiao-Xiao Zheng, et al.Frontiers in Endocrinology|August 29, 2022
A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survivalWu-Hu Zhang, He-Li Gao, Wen-Sheng Liu, et al.Scientific Reports|January 13, 2016
Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mLJin-Feng Xiang, Wen-Quan Wang, Liang Liu, et al.World Journal of Gastroenterology|June 17, 2021
Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasmsDeng Han, Yuan-Liang Li, Zhi-Wei Zhou, et al.Oncotarget|January 9, 2016
Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burdenLiang Liu, Hua-Xiang Xu, Wen-Quan Wang, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 30, 2018
Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinomaHua-Xiang Xu, Shuo Li, Chun-Tao Wu, et al.Pageof 11